A vaccine hesitancy is going to be, and it is a major issue not among general populations, but even for healthcare workers. And the responses that I receive is that it was developed too quickly, it wasn't really tested for long. But I want to assure that the messenger RNA platforms, for example, for the Pfizer and the Moderna have been in place for a long time. I'll give you an example, CMV vaccine or other virus vaccine that have been tested. So this particular technology has been in place for years now. The reason the pressure to develop was because of the pandemic for us to be getting there. If you look at the data today, about 30% of the US population is fully vaccinated. And so what there is reporting, and we haven't seen any adverse events, there is a lot of question about long-term effects. But if you understand the way the vaccine works, I do not foresee any long-term effects that people might be worried about. And when the adverse events were noted there out in the community, for example, there was a big concern for J&J. So I think there's a lot of transparency about the development and efficacy and the safety of these vaccines. So I encourage everybody who can get the vaccine to get the vaccine. My daughter got the vaccine. I was first in line just because we felt that looking at the data, it was safe. And if I can do it, I would encourage my patients to do it too.